Ms. Lisa Ann Butterworth, CRNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 17015 Old Orchard Rd, Lewes, DE 19958 Phone: 022-575-3723 |
Sara W Ruby, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1535 Savannah Rd, Lewes, DE 19958 Phone: 302-645-4700 Fax: 302-645-1038 |
Ann Marie Stafford, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1535 Savannah Rd, Lewes, DE 19958 Phone: 302-645-4700 Fax: 302-645-1038 |
Ms. Katie Lynn Lawrence, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1535 Savannah Rd, Lewes, DE 19958 Phone: 302-645-4700 Fax: 302-645-1042 |
News Archive
AVITA Medical today announced that results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL Autologous Cell Harvesting Device were presented in the plenary session at the U.S. Defense Department Military Health System Research Symposium (MHSRS) in Kissimmee, Florida.
In 2006, Massachusetts was on the same brink that the entire nation is on today: the brink of expanding health insurance to cover far more people than before, through government-driven, market-based reform.
Follow-up care for breast cancer patients costs less if it is conducted by nurses rather than physicians, yet there is no difference in the patients' anxiety, depression, satisfaction or outcome, according to research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.
At a meeting on the sidelines of the 67th U.N. General Assembly on Wednesday in New York, the MDG Advocacy Group - which comprises representatives from the private sector, academia, governments and civil society - "urged the international community to step up efforts for the final three years of the Millennium Development Goals (MDGs)," the U.N. News Centre reports.
CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.
› Verified 5 days ago